Cargando…
Is there a subgroup of long-term evolution among patients with advanced lung cancer?: Hints from the analysis of survival curves from cancer registry data
BACKGROUND: Recently, with the access of low toxicity biological and targeted therapies, evidence of the existence of a long-term survival subpopulation of cancer patients is appearing. We have studied an unselected population with advanced lung cancer to look for evidence of multimodality in surviv...
Autores principales: | Sanchez, Lizet, Lorenzo-Luaces, Patricia, Viada, Carmen, Galan, Yaima, Ballesteros, Javier, Crombet, Tania, Lage, Agustin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295230/ https://www.ncbi.nlm.nih.gov/pubmed/25496392 http://dx.doi.org/10.1186/1471-2407-14-933 |
Ejemplares similares
-
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
por: Rodriguez, Pedro C, et al.
Publicado: (2011) -
Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients
por: Lorenzo-Luaces, Patricia, et al.
Publicado: (2020) -
Control of Advanced Cancer: The Road to Chronicity
por: Lage, Agustin, et al.
Publicado: (2011) -
COVID-19 and Cancer in Cuba
por: Rubio, Maria Caridad, et al.
Publicado: (2020) -
Immunosenescence and gender: a study in healthy Cubans
por: García Verdecia, Beatriz, et al.
Publicado: (2013)